>>329
ççã«ããçŒç説ãåŠå®ãããã®ã§ããã°ãéã¹ããã€ãæ§æççè¬ã®è¬çäœçšåã³é®çäœçšãçŒçã«é¢ããããã¹ã¿ã°ã©ã³ãžã³åã³ã¯ãªãã·ããŒãŒïŒïŒ£ïœXïŒã®é¢äžãå
šãŠå
šåŠå®ãããŸãããïŒ
ççã«ããããªã¢ãŒãã«å容åšã®äœçšæ©åºã«é¢ããŠãå
šåŠå®ãããäºã«ãªããŸããããã®ç¹ã«ä»ããŠã©ã®æ§ãªèŠè§£ããæã¡ãïŒæ¯éãšã解æããé¡ãèŽããŸãã
ç柀ææã®èª¬ãå
šåŠå®ããããä»åºŠã¯æåªå€§åŠã®éº»é
ç§ææïŒïŒãçŠå³¶å»å€§åèªææïŒïŒãåŒã£åŒµãåºããŠãããã(ç¬)
âãããå
šåŠå®ïŒïŒïŒ(ç¬)
NSAIDsã®äž»ãªå¹æã¯ãççãããå±æã«ãããããã¹ã¿ã°ã©ã³ãžã³ïŒprostaglandinïŒPGïŒã®ç£çé»å®³ã§ãããçµç¹ãæå·ããããšããã¹ããªããŒãŒA2ã«ããã现èèã®ãªã³è質ããã¢ã©ããã³é
žãéé¢ããããéé¢ãããã¢ã©ããã³é
žã¯ã·ã¯ããªãã·ã²ããŒãŒïŒcyclooxygenaseïŒCOXïŒããã«ãªãã·ããŒãŒãå«ãPGHïŒprostaglandin HïŒåæé
µçŽ è€åäœã®åºè³ªãšãªããPGG2ãPGH2 ãžãšå€æããããããã«åçµç¹ã«ç¹ç°çãªPGåæé
µçŽ ã«ããPGE2ïŒ prostaglandin E2ïŒãªã©çš®ã
ã®ååŠäŒéç©è³ªãåæãããæå·çµç¹ãžæŸåºããããPGèªäœã«çºçäœçšã¯ãªããããã©ãžããã³ãªã©ã®çºçç©è³ªã®çŒçéŸå€ãäœäžãããããŸããå±æã§ã®è¡æµå¢å äœçšãè¡ç®¡ééæ§ã®äº¢é²ãçœè¡çã®æµžæœ€å¢å ãªã©ãççãå¢åŒ·ãããäœçšãæããããããã£ãŠãNSAIDsã¯éé¢ãããã¢ã©ããã³é
žããPGãåæããçµè·¯ã®åŸéé
µçŽ ã§ããã·ã¯ããªãã·ã²ããŒãŒã®åããé»å®³ããããšã«ããæççã»é®çäœçšãçºæ®ããã
ããŸããçºç±æã«ã¯çš®ã
ã®ãµã€ãã«ã€ã³ã®ç£çãä¿é²ãããèŠåºäžéšã«ããäœæž©èª¿ç¯äžæ¢ã«ãããPGE2ã®åæãå¢å ããäœæž©ãäžæãããããã«èŠåºäžéšã«åãããããNSAIDsã¯çºç±æã«ç£çãããPGE2ã®åæãé»å®³ããããšã§ã解ç±äœçšãããããã